SSA
VXRT

Schonfeld Strategic Advisors’s Vaxart VXRT Stock Holding History

Schonfeld Strategic Advisors’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-39,700
Closed -$29K – 2338
2023
Q2 		$29K Buy
+39,700
New +$36.9K ﹤0.01% 1862
2022
Q4 		– Sell
-75,234
Closed -$164K – 3052
2022
Q3 		$164K Buy
75,234
+24,276
+48% +$83.7K ﹤0.01% 2409
2022
Q2 		$179K Buy
+50,958
New +$190K ﹤0.01% 1943
2021
Q3 		– Sell
-47,500
Closed -$356K – 2499
2021
Q2 		$356K Buy
+47,500
New +$332K ﹤0.01% 1364

Other funds holding VXRT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Schonfeld Strategic Advisors's VXRT Position: Q3 2023 in Review

Schonfeld Strategic Advisors sold out of Vaxart (VXRT) in Q3 2023, closing a stake of 39,700 shares — an estimated $29K sold.

Schonfeld Strategic Advisors first reported a position in VXRT in Q2 2021 and held it in 4 quarters. The position peaked at $356K in Q2 2021. 96 funds tracked by Wall St. Rank hold VXRT as of Q3 2023.

  • Schonfeld Strategic Advisors reported no remaining Vaxart position as of Q3 2023 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 39,700 Vaxart shares in Q3 2023, an estimated $29K.
  • Schonfeld Strategic Advisors first reported a position in Vaxart in Q2 2021 and held it in 4 quarters.
  • Schonfeld Strategic Advisors's Vaxart position peaked at $356K in Q2 2021.
  • 96 funds tracked by Wall St. Rank held Vaxart as of Q3 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.